Healthcare / Medical Care FacilitiesThailand
$29.75
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $361.6M · quality 60.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.4B
P/E
15.2x
↓EV/EBITDA
6.9x
↓ROE
11.8%
↑Gross Margin
26.0%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.3%
FCF CAGR
+19.6%
FCF margin
10.4%
FCF / Net income
0.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.77B · net income $394.8M · FCF $289.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.77B | $2.77B | $2.71B | $2.40B | $2.59B |
| Net Income | $394.8M | $394.8M | $434.9M | $350.6M | $425.4M |
| EBITDA | $591.6M | $591.6M | $641.0M | $540.5M | $610.1M |
| EPS | 2.19 | 2.19 | 2.42 | 1.95 | 2.36 |
| Gross Margin | 26.0% | 26.0% | 28.5% | 26.7% | 29.7% |
| Operating Margin | 16.8% | 16.8% | 19.2% | 17.6% | 20.2% |
| Net Margin | 14.2% | 14.2% | 16.1% | 14.6% | 16.4% |
| Balance Sheet | |||||
| Current Ratio | 4.83 | 4.83 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $289.3M | $289.3M | $372.7M | $361.6M | $169.3M |
| Returns | |||||
| ROE | 11.8% | 11.8% | 14.2% | 12.8% | 17.1% |
| Valuation | |||||
| P/E | 15.18 | 15.18 | 14.39 | 17.86 | 15.25 |
| EV/EBITDA | 6.91 | 6.91 | 7.75 | 9.20 | 9.47 |
| P/B | 1.60 | 1.60 | 2.05 | 2.29 | 2.61 |
| Growth & Yield | |||||
| Revenue Growth | 2.4% | 2.4% | 12.6% | -7.1% | — |
| EPS Growth | -9.5% | -9.5% | 24.1% | -17.4% | — |
| Dividend Yield | 1.9% | 1.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.4%
EPS terminal req.
$2.64
Spread vs growth
-15.9%
5Y implied EPS CAGR
7.8%
EPS terminal req.
$3.19
Spread vs growth
-17.3%
10Y implied EPS CAGR
8.9%
EPS terminal req.
$5.14
Spread vs growth
-18.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-0.4%
Start / end P/E
13.6x → 14.7x
EPS bridge
2.42 → 2.19
Residual
-0.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.